welcome

Hi visitor,
Thank you for visiting my blog. I highly appreciate if you could leave a comment on the site in general or any particular post. It would be helpful for me and other followers.
Showing posts with label general. Show all posts
Showing posts with label general. Show all posts

Monday, January 5, 2015

Anaesthetic management of a case of idiopathic intracranial hypertension

Anaesthetic management of a case of idiopathic intracranial hypertension

INTRODUCTION

Idiopathic intracranial hypertension (IIH) was first described in 1893. Patients with IIH have a classical picture of headache, papilledema, and a raised cerebrospinal fluid (CSF) pressure of more than 25 mmHg. It is more common in women than in men (3:1) with the highest incidence seen in obese women of reproductive age group (20-45 years). The most common presenting symptoms are manifestations of generalized intracranial hypertension, normally headache and visual obscuration. Diplopia, pulsatile tinnitus, nausea and vomiting may be present in about 50% of patients, with neck/back/shoulder pain or radicular pain less frequent.[] The major risk of IIH is visual loss, which may be permanent despite medical therapy. It seems that the symptoms worsen during pregnancy in 50% of the patients and usually resolve postpartum.[]

CASE REPORT

A 45-year-old female, weighing 70 kg presented with complaints of headache, menorrhagia and pain in the abdomen was admitted to our hospital. She was posted for transcervical resection of the endometrium and patient had a past history of headache and blurring of vision 2 years ago and was diagnosed to have IIH and was on tablet acetazolamide 250 mg every 6 h. She had a history of lumbar CSF drainage twice. Patient had a history of hypertension and was on tablet atenolol once daily. On pre-operative examination, pulse was 70/min and blood pressure was under control. Other general and systemic examination was normal. All other investigations were within normal limits. Computer tomography brain was normal and magnetic resonance imaging revealed partially empty sella and no pituitary mass lesion, cerebral hemisphere and ventricles were normal. Fundus examination revealed chronic papilledema, optic nerve pallor and perimetry showed increased size of blind spot. Neurologist advised preoperative CSF pressure measurement and drainage if pressure is high. CSF manometry was performed in the lateral decubitus position and CSF pressure was more than 250 mm H2O with normal cytological and biochemical profile. 20 mL of CSF was drained with a 22 gauge Quincke's needle. After drainage the CSF pressure was 150 mm H2O. Patient was posted for surgery after 2 days.
On the day of surgery, injection glycopyrrolate (0.2 mg), injection midazolam (2 mg) and injection fentanyl (200 μg) were given intravenously as pre-medication. Anaesthesia was induced with propofol 175 mg and tracheal intubation was facilitated with vecuronium 5 mg injection plain lignocaine 2% 5 ml was given to attenuate pressor response. Anaesthesia was maintained with oxygen, nitrous oxide, propofol infusion, and vecuronium. Intra-operatively injection mannitol 1 g/kg was given. Monitoring included pulse oximetry, electrocardiogram (ECG), noninvasive blood pressure noninvasive blood pressure (NIBP), ETCO2, urine out-put and temperature. At the end of surgery neuro-muscular block was reversed with injection neostigmine 3.5 mg and glycopyrrolate 0.4 mg. She was shifted to post-operative recovery room and monitored for 48 h with pulse oximetry, ECG, NIBP, urine out-put, and temperature. She was completely asymptomatic at discharge.

DISCUSSION

IIH was first described by Quinke in 1893 and was called “serous meningitis.” IIH is caused by dural sinus thrombosis, a reduction in corticosteroid therapy, hormonal imbalance, vitamin A toxicity, anabolic corticosteroids, long-term tetracycline, hormonal contraceptives, lithium, and pregnancy.[] Theories of IIH pathophysiology include increased venous sinus pressure, decreased spinal fluid absorption, increased spinal fluid secretion, increased blood volume and brain oedema.[] The various treatment modalities used in patients include corticosteroids, acetazolamide, diuretics, repeated lumbar puncture and surgery. The goals of treatment of IIH involve a reduction of intracranial pressure to control symptoms and prevent pressure on the optic nerve and optic meninges, preserving vision. Serial lumbar punctures have a success rate of 30-40% when used alone. Generally, up to 30 ml of fluid is withdrawn to lower the intracranial pressure to normal.[] Our patient had a history of IIH since 2 years, was on tablet acetazolamide and showed response to medical therapy. Lumbar puncture was carried out twice to improve symptoms. In our patient, 20 cc of CSF was removed to keep the CSF pressure within normal limits.
From the literature, it has been found that IIH is more common in females in the age group 20-45 years.[] Women with more than 10% over their ideal body weight are 13 times more likely to develop IIH.[] Our patient was having a body mass index of >30 kg/m2. The mechanism proposed is that central obesity raises intra-abdominal pressure, which increases intra-pleural pressure and cardiac filling pressure, which in turn impedes venous return from the brain and leads to increased intracranial venous pressure, and increased intracranial pressure.[]
Neuraxial anaesthesia, spinal or epidural has been used successfully for caesarean section in patients with IIH. Since lumbar puncture for CSF drainage is a therapeutic modality for IIH, there is no indication to withhold spinal anaesthesia in these patients.[] Bedson and Plaat reported the combined spinal-epidural technique for delivery by caesarean section.[] Although, dural puncture is contraindicated in patients with increased intracranial pressure resulting from space occupying lesions due to risk of uncal herniation. However, it has been postulated that the uniform swelling and stiffness of the brain in IIH prevents herniation.[] Aly and Lawther reported a case of uncontrolled IIH successfully managed using an epidural catheter for analgesia in labour and delivery as well as temporary control of intracranial pressure.[] Abouleish and Ali had given spinal anaesthesia for caesarean section in patient with IIH.[]
In our patient, both surgeries were carried out simultaneously, so we had no option for regional anaesthesia. We have selected general anaesthesia as nephrectomy was carried out in the lateral decubitus position. If a patient with IIH requires general anaesthesia, the planned approach should minimize the risk of a rise in intracranial pressure associated with intubation, inadequate depth of anaesthesia and extubation. So, we have to take measures to avoid an increase in intracranial pressure (ICP) during the peri-operative period.
Propofol offers a number of pharmacological advantages for total intravenous anaesthesia in patients of raised ICP. It decreases cerebral blood flow and cerebral oxygen consumption and increases cerebrovascular resistance. It could offer cerebral protection.[] The synthetic short acting opioids like fentanyl lack any significant effect on ICP.
Induction and intubation may aggravate intracranial hypertension. Liberal doses of propofol combined with narcotics to achieve adequate depth of anaesthesia, mild to moderate hyperventilation, intravenous lignocaine bolus are the measures that prevent dangerous increase in ICP. We induced the patient with (200 μg) fentanyl and propofol and avoided succinylcholine for intubation as muscle fasciculation caused by succinylcholine, increase the intra cerebral blood volume and increase the ICP. Intubation in lighter planes of anaesthesia should be avoided. Atracurium causes histamine release, slightly increases the pulse rate and central system excitement, so we have used vecuronium in our patient. Vecuronium does not alter ICP or CSF dynamics and lack of cerebral effects have made vecuronium a popular choice in patients with raised ICP. Definitive measures used for decreasing the ICP include, mild head elevation, maintain EtCO2 between 25 mmHg and 30 mmHg, I.V. mannitol, continuous infusion of thiopentone or propofol, avoid hypoxia, hypercarbia, hyperthermia and hypotension.

CONCLUSION

In conclusion, although IIH is rare, there are special considerations for anaesthetic management in patients with this disorder. Even though, these patients have an elevated ICP, anaesthesia does not cause any detrimental effects in patients with IIH. So, we have to take measures to avoid increase in ICP during the perioperative period. Despite the presence of raised ICP in these patients, there is no specific contraindication to either spinal or epidural anaesthetic technique since uncal herniation does not occur in these patients. The main goal is to avoid further increases in ICP.

Residual neuromuscular blockade

Residual neuromuscular blockade

Residual neuromuscular blockade can be defined by inadequate neuromuscular recovery as measured  by objective neuromuscular monitoring. It is also referred to as residual paralysis, residual  curarisation, and residual neuromuscular block. More specifically, recent opinion suggests a definition  of inadequate train of four recovery of less than 0.9 (TOF <0 .9="" p="">
On a practical level, the concept of adequate neuromuscular recovery is intended as the return to a  basline muscular function, particularly the ability to breathe normally, maintain a patent airway, and  retain protective airway reflexes.
 INCIDENCE
current estimates are that around 40% of post-operative patients (who have been paralised)
arrive in PACU with TOF <0 .9="" 12="" and="" p="" tof="" with="">
ADVERSE EFFECTS OF RESIDUAL NEUROMUSCULAR BLOCKADE
The following tables detail the implications of residual neuromuscular blockade (these are more
illustrative than exhaustive)
Table 1: Physiological changes



Impaired muscle tone and
Coordination


Upper airway pharyngeal and oesophageal muscles    
Increased risk of aspiration Increased risk of airway obstruction        
Laryngeal muscles          
Increased risk of aspiration Impaired phonation
Impaired cough               
Respiratory muscles      
Impaired ventilation and oxygenation      
Impaired function of other muscles throughout                the body

Table 2: Clinical implications
Symptoms and signs of
 muscle weakness           
Difficulty breathing        
Generalised weakness 
Difficulty speaking          
Visual disturbances        
Patient distress               
Immediate critical respiratory events  in PACU               
Post-operative  hypoxaemia               
Upper   airway   obstruction
Later respiratory events
Prolonged ventilator weaning               
Post-operative  pulmonary complications    (eg. atelectasis, pneumonia)               
INVESTIGATIONS
 Clinical criteria for evaluating adequacy of muscle function include: assessment of a patient’s ability to maintain adequate head lift, jaw clench, grip strength, and tidal volume. These are unreliable predictors of neuromuscular recovery. For example, it is possible to maintain a 5 second head lift with  TOF <0 .52.="" addition="" are="" for="" function.="" in="" many="" not="" of="" p="" respiratory="" specific="" tests="" these="">
Train-of-four neuromuscular monitoring is commonly conducted with a subjective measurement, either  as a simple train of four count (TOFC) or train of four ratio (TOF). The latter refers to when there is  already a TOFC of 4, and subsequent assessment is made for fade in T4 compared to T1.
Double Burst Stimulation (DBS) is another method of neuromuscular monitoring, but is also
commonly measured in a subjective manner..
Objective measurement of neuromuscular monitoring is the only way of accurately assessing residual  neuromuscular blockade. In general, it is conducted via quantitative measurement of the strength of  contraction of a peripheral muscle (eg. adductor pollicis muscle in thumb) in response to peripheral  nerve stimulation (eg. ulnar nerve at wrist) produced by 2 stimulating electrodes. Each measurement  technique measures the force of contraction, either directly or by a factor that is proportional to force.
 Table 5: Common sites of peripheral nerve stimulation
Nerve:  Ulnar     nerve                   
Muscle:                Adductor             pollicis  
Action:  Thumb  adduction                           
Black:    1-2cm    proximal              to            wrist      crease  
Red:       2-3cm    proximal              to            black     

Nerve:  Facial    nerve                   
Muscle:                Orbicularis           oculi       and        Corrugator          supercilii                             
Action:  Twitching             of            eyelid    and        eyebrow                             
Black:    Just        anterior                to            tragus  
Red:       Lateral  to            outer     canthus                of            eye

Nerve:  Posterior tibial nerve    (sural    nerve)                 
Muscle:                Flexor   hallicus brevis                   
Action:  Plantar  flexion  of great                toe                        
Black:    Over posterior aspect of medial                malleolus, over posterior tibial   artery   
Red:       2-3cm    proximal to black             
REVERSAL  AGENT
It is good practice to always consider giving a reversal agent, unless there is objective neuromuscular  monitoring demonstrating a TOF >0.9 (giving neostigmine to fully recovered patients may decrease  upper airway muscle activity and tidal volume) . Adequate spontaneous recovery of train of four count should be established BEFORE giving reversal. When using anaesthetic techniques that do not potentiate neuromuscular blockers, eg. TIVA, a  minimum TOFC of 2 should be established. When using anaesthetic techniques that do potentiate        neuromuscular blockers, eg. inhalational volatiles, a TOFC of 4 should be established. This is to
ensure adequate antagonism by the reversal agent of the additional depth of neuromuscular blockade.

Table 5: Train of four count and physiological correlation              
Trainof  four count  %     neuromuscular blockade at muscle        
    4                                                      0–75%      
    3                                                      75%           
    2                                                      80%            
    1                                                      90%            
    0                                                      100%         
Reversal with subjective neuromuscular monitoring     
- TOFC 1 or zero = delay reversal
- TOFC 2 or 3 = give reversal
- TOFC 4 with fade = give reversal
- TOFC 4 with no perceived fade = give reversal, consider low dose (20 µg/kg) neostigmine
- TOFC 4 and >0.9 = withhold reversal
               
Reversal with objective neuromuscular monitoring       
- TOFC 0 or 1 = delay reversal
- TOFC 2 or 3 = give reversal
- TOFC 4 with < 0.4 = give reversal
- TOFC 4 with 0.4-0.9 = give reversal, consider low dose neostigmine
- TOFC 4 and >0.9 = withhold reversal
               
Reversal guidelines with clinical neuromuscular monitoring
- Only consider reversal when spontaneous muscle activity is present
- Remember that clinical tests of adequate reversal are unreliable indicators of neuromuscular
Blockade
TREATMENT OF RESIDUAL NEUROMUSCULAR BLOCKADE
1. ABC. Basic resuscitation is the foundation on which the following steps are to be considered:
support the patient’s airway, breathing, and circulation.
2. Rule out other potential causes. Is this really residual neuromuscular blockade? Check nerve
stimulator, use a different nerve-muscle combination.
3. Consider giving reversal. In some institutions, it is still not routine for reversal to be used,
largely due to concerns of cholinergic symptoms of nausea and bradycardia with  cholinesterase inhibition.
4. Wait. Have you given enough time for the reversal to have effect? Is the patient stable enough  to tolerate watchful waiting.
5. Consider giving additional reversal. Note however, that if there is already complete
inhibition of acetylcholinesterase, giving further neostigmine will not serve any useful
purpose.
6. Treat potentiating factors. Many factors prolong neuromuscular blockade, such as
inhalational agents, opioids, acidosis, hypothermia, hypercarbia, hypoxia.

7. Consider alternative methods of reversal (Sugammadex if available)

Wednesday, June 29, 2011

Peripheral Nerve Stimulation


Peripheral Nerve Stimulation
Indications
Because of the variation in patient sensitivity to neuromuscular blocking agents, the neuromuscular function of all patients receiving intermediate- or long-acting neuromuscular blocking agents should be monitored. In addition, peripheral nerve stimulation is helpful in assessing paralysis during rapid-sequence inductions or during continuous infusions of short-acting agents. Furthermore, peripheral nerve stimulators can help locate nerves to be blocked by regional anesthesia.
Contraindications
There are no contraindications to neuromuscular monitoring, although certain sites may be precluded by the surgical procedure.
Techniques & Complications
A peripheral nerve stimulator delivers a current of variable frequency and amplitude to a pair of either ECG silver chloride pads or subcutaneous needles placed over a peripheral motor nerve. The evoked mechanical or electrical response of the innervated muscle is observed. Although electromyography provides a fast, accurate, and quantitative measure of neuromuscular transmission, visual or tactile observation of muscle contraction is usually relied upon in clinical practice. Ulnar nerve stimulation of the adductor pollicis muscle and facial nerve stimulation of the orbicularis oculi are most commonly monitored. Because it is the inhibition of the neuromuscular receptor that needs to be monitored, direct stimulation of muscle should be avoided by placing electrodes over the course of the nerve and not over the muscle itself. To deliver a supramaximal stimulation to the underlying nerve, peripheral nerve stimulators must be capable of generating at least a 50-mA current across a 1000- load. This current is uncomfortable for a conscious patient. Complications of nerve stimulation are limited to skin irritation and abrasion at the site of electrode attachment.

Sunday, May 1, 2011

Coagulation Abnormalities Made Easy

 Coagulation Abnormalities Made Easy
Linda L. Liu, M.D. San Francisco, California

Back decades ago, the coagulation cascade was taught in terms of 2 pathways, the intrinsic versus the extrinsic.


Figure 1 shows a very simplified version of the proposed waterfall/ cascade model of the coagulation system.
Unfortunately, as we started to understand more about the coagulation system, it became more and more complex.
Many of the enzymes were found to be cofactors or were precursors to the active form. We also found that the 2
pathways were not completely separate in function. They appeared to be an intertwined system where modulation
of one arm may or may not affect the second arm. The modern view of coagulation is to actually look at the
coagulation system as a series of steps, 1) initiation, 2) amplification, and 3) propagation, as opposed to distinct
pathways, (1) but the old 2 pathway model is still beneficial in terms of helping us understand what abnormal
coagulation tests mean. This chapter will exam some causes of abnormal coagulation in the perioperative period and
discuss agents that are used to modulate the coagulation system.
Figure 1: Waterfall/ Cascade Model of the Coagulation System